Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT06350097
Title Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer (TROPION-Lung14)
Acronym TROPION-Lung14
Recruitment Not yet recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors AstraZeneca
Indications
Therapies
Age Groups: senior | adult
Covered Countries AUS

Facility Status City State Zip Country Details
Research Site Clayton 3168 Australia Details
Research Site Kogarah 2217 Australia Details
Research Site Changchun 130000 China Details
Research Site Chongqing 400030 China Details
Research Site Jinan 250021 China Details
Research Site Jinan 250117 China Details
Research Site Kunming 650118 China Details
Research Site Linhai 318000 China Details
Research Site Shanghai 200030 China Details
Research Site Seoul 06351 Korea, Republic of Details
Research Site Seoul 120-752 Korea, Republic of Details
Research Site Seoul 13620 Korea, Republic of Details
Research Site Taipei City 106 Taiwan Details
Research Site Taipei 10002 Taiwan Details
Research Site Taoyuan 333 Taiwan Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field